LENVIMA

Identification of Lenvima

No description

Google image searchProduct monograph

Active ingredient

lenvatinib (lenvatinib mesylate), 14 MG/DOSE

DIN: 02450313

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Description: EACH 14 MG DAILY DOSE CONTAINS 1 X 10 MG & 1 X 4 MG CAPSULES PER BLISTER

Schedule: Prescription

Company: EISAI LIMITED

Date: 31-MAR-2016

ATC:

Search on Google